Artículos del autor

solaci

Other

ESC 2022 | PERSPECTIVE: Efficacy and Safety of Sacubitril/Valsartan Compared with Valsartan in Cognitive Function of Patients with Cardiac Failure and Preserved Function

About 30 to 80% of patients with heart failure (HF) have some sort of cognitive impairment, with...
solaci -
Other

ESC 2022 | SECURE Trial

This study, presented by Dr. Valentin Fuster, focused on the importance of medical treatment compliance, initially showing...
solaci -
Other

ESC 2022 | TIME STUDY

The TIME study, presented by Dr. Thomas MacDonald, is a randomized study of over 21,000 patients with...
solaci -
ESC 2022

ESC 2022

Here are the most important scientific articles of the ESC 2022 Congress. If you cannot view the articles,...
solaci -
Structural heart disease

TAVR in Bicuspid Patients: Are Outcomes the Same in Men and Women?

Bicuspid aortic valve stenosis (BAV) has not yet been analyzed in large, randomized studies, and TAVR in...
solaci -
Acute coronary syndromes

Aspiration Thrombectomy in Acute Coronary Syndrome: Is the Japanese Perspective a Strategy to Emulate?

Aspiration thrombectomy (AT) in patients with high thrombotic burden could pathophysiologically reduce thrombus burden, decrease distal embolization,...
solaci -
Institutional News

IV Summit Minimalist TAVI – Step by Step: How to Streamline procedures?”

Next August 30 and 31 at 7:30 p.m. (Argentina / Brazil time) we will hold a new...
solaci -
Chronic Ischemic cardiopathy

Optimization by IVUS after FFR Guided PCI: Are There Clinical Benefits for Patients?

Percutaneous coronary interventions have improved during the last decade with 15% rate of target vessel failure (TVF)...
solaci -